2025 HCPCS code J7301
Effective Date: N/A Contraceptive Systems Feed
Levonorgestrel-releasing intrauterine contraceptive system (Skyla), 13.5 mg.
Medical necessity for Skyla should be supported by documentation that the patient desires a long-acting, reversible form of contraception, a discussion of the risks and benefits of the various available IUDs, as well as any contraindications.
In simple words: Skyla is a small, T-shaped plastic device placed inside the uterus to prevent pregnancy for up to three years. It releases a small amount of the hormone levonorgestrel.
This code represents one unit of a 13.5 mg levonorgestrel-releasing intrauterine contraceptive system (Skyla). It is a hormonal intrauterine device (IUD) that is placed in the uterus to prevent pregnancy for up to 3 years. The device itself releases levonorgestrel, a progestin hormone. This code represents the device only and does not include the insertion procedure.
Example 1: A 25-year-old woman requests a long-acting reversible contraceptive and chooses the Skyla IUD. Her physician inserts the device during an office visit., A patient's Skyla IUD is due for replacement after three years and her physician inserts a new Skyla IUD at her annual wellness visit., A patient who is dissatisfied with her current method of birth control decides she wants an IUD. After discussing her options with her doctor, she decides Skyla is the best option.
Documentation should include the type of IUD inserted (Skyla), the dosage (13.5mg), the date of insertion and information regarding any complications during insertion (if any). Supporting clinical documentation of medical necessity should also be recorded.
- Specialties:Obstetrics and Gynecology, Family Medicine
- Place of Service:Office